Mobilization of hematopoietic stem cells in patients undergoing HSCT as a treatment of early diabetes type 1
Conclusion The mobilization of hematopoietic stem cells with CY+G-CSF in patients with early diabetes type 1 is efficient and the underlying diabetes does not impair the efficiency of hematopoietic stem cell collection.
Source: Acta Haematologica Polonica - Category: Hematology Source Type: research
More News: Chemotherapy | Diabetes | Diabetes Type 1 | Endocrinology | Hematology | Pancreas | Stem Cell Therapy | Stem Cells | Transplants